DIC早期诊断的实验研究.PDF
http://www.100md.com
第1页 |
参见附件(84kb)。
弥散性血管内凝血早期诊断的实验研究
李君君1
陈方平2
颜家运1
余海仁1
颜向军1
[摘要] 目的:探索弥散性血管内凝血(DIC)早期诊断的实验指标。方法:采用 EL ISA双抗体夹心法测定血
浆凝血酶原片段 1 + 2 (F1 + 2) 、 D2二聚体(D2D) ,采用免疫浊度法测定血清抗凝血酶 Ⅲ(AT2Ⅲ) 。结果:各期 DIC
组患者血浆 F1 + 2、 D2D含量均显著升高 ,AT2Ⅲ含量显著降低 ,且与可疑 DIC组及正常对照组比较差异均有极显
著性意义( P < 0. 01) 。在早期 DIC组中 ,F1 + 2阳性率为 100 % ,D2D 及 AT2Ⅲ阳性率为93. 8 % ,敏感性远远高于
DIC常规实验室检查。结论:F1 + 2、 AT2Ⅲ、 D2D是能早期反映体内凝血、抗凝及纤溶系统激活的敏感性指标之一 ,在 DIC早期诊断中有着重要实用价值。
[关键词] 血管内凝血 ,弥散性;凝血酶原片段 1 + 2 ;抗凝血酶 Ⅲ;D2二聚体
[中图分类号] R554 [文献标识码] A [文章编号] 100422806 (2003) 0220082203
Experiment study of the early diagnosis of dissminated
intravascular coagulation
L I J unjun
1
CHEN G Fangping
2
YA N Jiayun
1
YU Hai ren
1
YA N Xiangjun
1
(
1
Department of Hematology , the First Affiliated Hostiptal ,Nanhua University ,Hengyang 421001 ,China ;
2
Department of Hematology ,Xiangya Hospital ,Cont rical South University)
Abstract Objective :In order to study the laboratory indexes of early Disseminated int ravascular coagulation (DIC)
diagnosis.Method :67 patients were divided into 3 groups :early stage DIC group , middle and later period DIC group ,suspicious DIC group. F1 + 2 and D2dimer were measured by EL ISA , AT2Ⅲwas measured by immunoturbidimet rische
method. Result :The Levels of F1 + 2 and D2dimer in early stage DIC group〔(3. 96 ±1. 64 nmoL/ L) , (2. 85 ±1. 36 ,mg/ L) ? x ±s respectively〕and middle and later period DIC group (3. 82±2. 05nmoL/ L) , (6. 12 ±3. 11 mg/ L) were
ext remely increased , whereas the level of AT 2Ⅲin early stage DIC group (114. 5 ±30. 2 mg/ L) and middle and later
period DIC group (136. 8 ±33. 5 mg/ L) were decreased. Significant differences of these parameters in each period of
DIC existed compared with suspicious DIC group and normal cont rols ( P < 0. 01) . F1 + 2 and D2dimer levels in suspi2
cious DIC group (1. 70 ±0. 33 nmol/ L) , (1. 51 ±1. 42 mg/ L) were increased too , wherease AT 2Ⅲlevel (197. 5 ±
41. 0 mg/ L) was decreased , Significant differences of these parameters existed as compared with the normals ( P <
0. 01) . The positive rate of F1 + 2 was ext remely high (100 %) , while D2D and AT2Ⅲwere high too (93. 8 %) . Conclu2
sion :F1 + 2 ,D2D and AT2Ⅲare sensitive indexes , which can early reflect coagulation , anti2coagulation and Fibrinolysis.
they had important practical value in the early diagnosis of DIC.
Key words Disseminated int ravascular coagulation ;Prothrombin f ragment1 + 2 ;Antithrombin Ⅲ; D2dimer
弥散性血管内凝血(DIC)是发生于许多疾病
过程中的一种获得性血栓2出血综合征 ,其症状凶
险 ,进展快速 ,如不及时诊断和处理 ,常常危及生
命。故当有可能导致 DIC 的基础疾病存在时 ,早
期诊断、早期预防是 DIC 治疗至关重要的环节。
本研究通过对血栓前状态部分分子标志物凝血酶
原片段 1 + 2 ( F1 + 2) 、 D2二聚体(D2D)及血清抗凝
血酶 Ⅲ(AT2Ⅲ)的定量检测 ,并与常规实验指标比
较 ,以探讨 3 种指标在 DIC 早期诊断中的应用价
值 ,为早期诊断和治疗DIC提供新思路。
1 对象与方法
1. 1 研究对象
DIC患者的诊断依据为我国血栓与止血学术
会议制定的标准〔 1〕;可疑DIC患者均符合: ①存在
引起DIC的基础疾病; ②具有一项以上 DIC 临床
1
南华大学附属第一医院血液科(湖南衡阳 ,421001)
2
中南大学湘雅医院血液科
表现; ③ DIC常规检查异常 ,但达不到诊断标准。
DIC组:35 例 ,男17 例 ,女18 例;年龄17~68
岁 ,平均41. 6岁。结合临床病史、体征、实验室检
测结果 ,根据 DIC 病程将其再分为早期及中晚期
DIC两组 ,其中重症感染 11 例 ,产科疾病 8 例 ,急
性白血病 7 例(M34 例 ,M52 例 ,M21 例) ,恶性淋
巴瘤 2 例 ,恶性组织细胞病(简称恶组) 2 例 ,前列
腺癌 1 例 ,系统性红斑狼疮 1 例 ,中暑 1 例 ,脑血
管意外 1 例 ,肺癌术后 1 例 ......
李君君1
陈方平2
颜家运1
余海仁1
颜向军1
[摘要] 目的:探索弥散性血管内凝血(DIC)早期诊断的实验指标。方法:采用 EL ISA双抗体夹心法测定血
浆凝血酶原片段 1 + 2 (F1 + 2) 、 D2二聚体(D2D) ,采用免疫浊度法测定血清抗凝血酶 Ⅲ(AT2Ⅲ) 。结果:各期 DIC
组患者血浆 F1 + 2、 D2D含量均显著升高 ,AT2Ⅲ含量显著降低 ,且与可疑 DIC组及正常对照组比较差异均有极显
著性意义( P < 0. 01) 。在早期 DIC组中 ,F1 + 2阳性率为 100 % ,D2D 及 AT2Ⅲ阳性率为93. 8 % ,敏感性远远高于
DIC常规实验室检查。结论:F1 + 2、 AT2Ⅲ、 D2D是能早期反映体内凝血、抗凝及纤溶系统激活的敏感性指标之一 ,在 DIC早期诊断中有着重要实用价值。
[关键词] 血管内凝血 ,弥散性;凝血酶原片段 1 + 2 ;抗凝血酶 Ⅲ;D2二聚体
[中图分类号] R554 [文献标识码] A [文章编号] 100422806 (2003) 0220082203
Experiment study of the early diagnosis of dissminated
intravascular coagulation
L I J unjun
1
CHEN G Fangping
2
YA N Jiayun
1
YU Hai ren
1
YA N Xiangjun
1
(
1
Department of Hematology , the First Affiliated Hostiptal ,Nanhua University ,Hengyang 421001 ,China ;
2
Department of Hematology ,Xiangya Hospital ,Cont rical South University)
Abstract Objective :In order to study the laboratory indexes of early Disseminated int ravascular coagulation (DIC)
diagnosis.Method :67 patients were divided into 3 groups :early stage DIC group , middle and later period DIC group ,suspicious DIC group. F1 + 2 and D2dimer were measured by EL ISA , AT2Ⅲwas measured by immunoturbidimet rische
method. Result :The Levels of F1 + 2 and D2dimer in early stage DIC group〔(3. 96 ±1. 64 nmoL/ L) , (2. 85 ±1. 36 ,mg/ L) ? x ±s respectively〕and middle and later period DIC group (3. 82±2. 05nmoL/ L) , (6. 12 ±3. 11 mg/ L) were
ext remely increased , whereas the level of AT 2Ⅲin early stage DIC group (114. 5 ±30. 2 mg/ L) and middle and later
period DIC group (136. 8 ±33. 5 mg/ L) were decreased. Significant differences of these parameters in each period of
DIC existed compared with suspicious DIC group and normal cont rols ( P < 0. 01) . F1 + 2 and D2dimer levels in suspi2
cious DIC group (1. 70 ±0. 33 nmol/ L) , (1. 51 ±1. 42 mg/ L) were increased too , wherease AT 2Ⅲlevel (197. 5 ±
41. 0 mg/ L) was decreased , Significant differences of these parameters existed as compared with the normals ( P <
0. 01) . The positive rate of F1 + 2 was ext remely high (100 %) , while D2D and AT2Ⅲwere high too (93. 8 %) . Conclu2
sion :F1 + 2 ,D2D and AT2Ⅲare sensitive indexes , which can early reflect coagulation , anti2coagulation and Fibrinolysis.
they had important practical value in the early diagnosis of DIC.
Key words Disseminated int ravascular coagulation ;Prothrombin f ragment1 + 2 ;Antithrombin Ⅲ; D2dimer
弥散性血管内凝血(DIC)是发生于许多疾病
过程中的一种获得性血栓2出血综合征 ,其症状凶
险 ,进展快速 ,如不及时诊断和处理 ,常常危及生
命。故当有可能导致 DIC 的基础疾病存在时 ,早
期诊断、早期预防是 DIC 治疗至关重要的环节。
本研究通过对血栓前状态部分分子标志物凝血酶
原片段 1 + 2 ( F1 + 2) 、 D2二聚体(D2D)及血清抗凝
血酶 Ⅲ(AT2Ⅲ)的定量检测 ,并与常规实验指标比
较 ,以探讨 3 种指标在 DIC 早期诊断中的应用价
值 ,为早期诊断和治疗DIC提供新思路。
1 对象与方法
1. 1 研究对象
DIC患者的诊断依据为我国血栓与止血学术
会议制定的标准〔 1〕;可疑DIC患者均符合: ①存在
引起DIC的基础疾病; ②具有一项以上 DIC 临床
1
南华大学附属第一医院血液科(湖南衡阳 ,421001)
2
中南大学湘雅医院血液科
表现; ③ DIC常规检查异常 ,但达不到诊断标准。
DIC组:35 例 ,男17 例 ,女18 例;年龄17~68
岁 ,平均41. 6岁。结合临床病史、体征、实验室检
测结果 ,根据 DIC 病程将其再分为早期及中晚期
DIC两组 ,其中重症感染 11 例 ,产科疾病 8 例 ,急
性白血病 7 例(M34 例 ,M52 例 ,M21 例) ,恶性淋
巴瘤 2 例 ,恶性组织细胞病(简称恶组) 2 例 ,前列
腺癌 1 例 ,系统性红斑狼疮 1 例 ,中暑 1 例 ,脑血
管意外 1 例 ,肺癌术后 1 例 ......
您现在查看是摘要介绍页,详见PDF附件(84KB,3页)。